BMY-20661
UNII HZ2Q7K8V8A

Substance Identification & Data

This profile provides standardized clinical and technical data for Bmy-20661, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HZ2Q7K8V8A.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 106260-91-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
HZ2Q7K8V8A
CAS Registry Number
106260-91-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BMY-20661
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C19H24N4O4
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
QBICJHHCQYFVMI-UHFFFAOYSA-N
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
c1(c2c(ccn1)occ2)N3CCN(CCCCN4C(COCC4=O)=O)CC3

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Bmy-20661. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

3,5-MORPHOLINEDIONE, 4-(4-(4-FURO(3,2-C)PYRIDIN-4-YL-1-PIPERAZINYL)BUTYL)-
4-(4-(4-(FURO(3,2-C)PYRIDIN-4-YL)PIPERAZIN-1-YL)BUTYL)-3,5-MORPHOLINEDIONE

Technical Codes

BMY-20661